Profiles
Matthew Young

Matthew Young, PhD

Associate Professor
Biochemistry and Molecular Biology
Profiles
Lynn Rheinecker, PharmD

Lynn Rheinecker, PharmD

Assistant Professor
Family and Community Medicine
Profiles
Lynn Rheinecker, PharmD

Lynn Rheinecker, PharmD

Assistant Professor
Family and Community Medicine
Profiles
Lynn Rheinecker, PharmD

Lynn Rheinecker, PharmD

Assistant Professor
Family and Community Medicine
Profiles
Lynn Rheinecker, PharmD

Lynn Rheinecker, PharmD

Assistant Professor
Family and Community Medicine
General Results
Kathleen Quinn

Kathleen Quinn

SIU Neuroscience Institute Researcher
Neurology
Profiles
Nicholas Weshinskey

Nicholas Weshinskey, Ph.D., NCC

Assistant Professor, Year One Curriculum Director
Medical Education
Profiles
Nicholas Weshinskey

Nicholas Weshinskey, Ph.D., NCC

Assistant Professor, Year One Curriculum Director
Medical Education
Profiles
Nicholas Weshinskey

Nicholas Weshinskey, Ph.D., NCC

Assistant Professor, Year One Curriculum Director
Medical Education
Trial
Neurology

Phase 2b/3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety and Efficacy of Dipraglurant (ADX48621) for the Treatment of Dyskinesia in Patients with Parkinson's Disease Receiving Levodopa-based

Active recruiting
The purpose of this study is to evaluate the effectiveness, safety, and tolerability of the investigational drug, dipraglurant (ADX48621), in subjects with Parkinson’s disease (PD) and levodopa-induced dyskinesia (LID).
Contact: Stephanie Kohlrus 217-545-3013
Subscribe to